These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy.
    Author: Tárnok F, Deák G, Jávor T, Mózsik G, Nagy L, Patty I.
    Journal: Int J Tissue React; 1983; 5(3):315-21. PubMed ID: 6654627.
    Abstract:
    Prospective randomized studies were carried out in 136 endoscopically verified duodenal ulcer patients to evaluate the healing effects of the following four-week courses of treatment: placebo, atropine (3 X 0.66 mg), carbenoxolone (3 X 100-3 X 50 mg), atropine + cyproheptadine (3 X 4 mg), atropine + carbenoxolone. Antacid powder was also supplied for relief of symptoms as required. Ulcer healing (incidence and planimetrically calculated surface), changes in complaints, antacid consumption and subjective and objective side-effects were evaluated during each type of treatment. The effectiveness of the different treatments were compared according to these points. The results showed: (i) that atropine, atropine + cyproheptadine and carbenoxolone all had good ulcer healing effects (75%, 74%, 62% respectively), according to incidence; (ii) that the atropine + carbenoxolone combination did not have a better healing effect (44%) than placebo (41%); (iii) that there were no significant differences among the planimetrically calculated ulcer healing effects during the different types of treatment; (iv) that the earliest diminution in complaints the greatest increase in body weight were found in the atropine + cyproheptadine group; (v) that there were no objective side-effects during the four-week treatment periods; and (vi) that definite subjective side-effects were observable only in the two atropine-treated groups. The findings led to the conclusion that the atropine + cyproheptadine combination is of value for the treatment of duodenal ulcer, while the atropine + carbenoxolone combination presents no practical advantages.
    [Abstract] [Full Text] [Related] [New Search]